Skip to Content

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

At the 2024 San Antonio Breast Cancer Symposium, Dr. and PhD student Demet Özcan presented a study from the Danish Breast Cancer Study. In this MEDtalk, she presents the study that confirms the prognostic value of tumor-infiltrating lymphocytes (TILs) in breast cancer patients undergoing radiotherapy, validating earlier findings with modern treatment standards.

Demet Özcan

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top